Kala Pharmaceuticals Inc. (KALA)
NASDAQ: KALA
· Real-Time Price · USD
8.04
0.17 (2.16%)
At close: Aug 14, 2025, 3:59 PM
8.10
0.68%
Pre-market: Aug 15, 2025, 09:09 AM EDT
Kala Pharmaceuticals Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | n/a | n/a | 254K | n/a | n/a | n/a | 70K | n/a | n/a | n/a | 1.23M | 420K | 2.1M | 1.37M | 1.86M | 3.07M | 3.05M | 3.27M |
Cost of Revenue | 67K | n/a | 69K | 63K | 61K | 66K | 70K | 157K | 77K | n/a | 2.56M | 11K | 1.77M | 775K | 1.42M | 908K | 1.02M | 755K |
Gross Profit | -67K | -68K | 127K | -63K | -61K | -66K | -70K | -157K | -77K | n/a | -1.33M | 409K | 326K | 597K | 438K | 2.16M | 2.04M | 2.51M |
Operating Income | -11.03M | -10.67M | -9.46M | -9.99M | -9.61M | -11.93M | -9.11M | -8.53M | -9.6M | -11.68M | -10.25M | -14.57M | -26.82M | -30.85M | -46.81M | -26.07M | -29.05M | -28.31M |
Interest Income | 407K | 463K | 478K | 570K | 504K | 504K | 610K | 708K | 718K | 675K | 354K | 234K | 68K | 8K | 12K | 16K | 33K | 43K |
Pretax Income | -11.15M | -8.95M | -8.18M | -8.95M | -9.58M | -11.81M | -8.63M | -8.7M | -10.41M | -14.46M | -12.84M | 29.07M | -28.11M | -32.94M | -47.57M | -28.13M | -36.5M | -30.41M |
Net Income | -11.15M | -8.95M | -8.18M | -8.95M | -9.58M | -11.81M | -8.63M | -8.7M | -10.41M | -14.46M | -13.86M | 29.07M | -27.26M | -33M | -47.57M | -28.13M | -36.5M | -30.41M |
Selling & General & Admin | 4.64M | 4.59M | 4.2M | 4.4M | 4.32M | 5.42M | 4.55M | 4.79M | 4.96M | 6.03M | 5.83M | 9.55M | 22.67M | 26.98M | 24.03M | 25.35M | 27.99M | 27.7M |
Research & Development | 6.23M | 6.05M | 5.19M | 5.17M | 5.26M | 6.35M | 4.72M | 5.55M | 4.28M | 4.04M | 3.32M | 5.39M | 4.47M | 4.47M | 2.41M | 2.88M | 3.09M | 3.13M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | -66K | n/a | n/a | n/a | 1.62M | -1.37M | n/a | 59K | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 10.88M | 10.65M | 9.39M | 9.57M | 9.57M | 11.71M | 9.27M | 10.35M | 9.24M | 11.68M | 9.15M | 14.94M | 27.15M | 31.45M | 26.44M | 28.23M | 31.08M | 30.82M |
Interest Expense | 1.08M | -1.09M | 1.39M | 1.48M | 1.46M | 1.46M | 1.47M | 1.46M | 1.41M | 1.47M | 1.58M | 1.45M | 2.21M | 2.04M | 2.08M | 2.07M | 2.09M | 2.14M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | -70K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 11.03M | 10.67M | 9.46M | 9.99M | 9.63M | 11.77M | 9.34M | 10.51M | 9.24M | 11.68M | 9.15M | 14.95M | 28.92M | 32.22M | 27.86M | 29.14M | 32.1M | 31.58M |
Income Tax Expense | n/a | n/a | -22.72K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.02M | n/a | -848K | 63K | n/a | 16K | n/a | 43K |
Shares Outstanding (Basic) | 6.51M | 6.35M | 4.69M | 4.63M | 3.03M | 2.81M | 2.71M | 2.55M | 2.39M | 2.07M | 1.61M | 1.5M | 1.47M | 1.47M | 1.3M | 1.3M | 1.29M | 1.23M |
Shares Outstanding (Diluted) | 6.51M | 6.35M | 4.69M | 4.63M | 3.03M | 2.81M | 2.71M | 2.55M | 2.39M | 2.07M | 1.61M | 1.51M | 1.47M | 1.47M | 1.3M | 1.31M | 1.29M | 1.23M |
EPS (Basic) | -1.71 | -1.41 | -1.74 | -1.93 | -3.16 | -4.2 | -3.18 | -3.41 | -4.36 | -6.99 | -8.6 | 19.39 | -18.5 | -22.41 | -36.56 | -21.62 | -28.27 | -24.66 |
EPS (Diluted) | -1.71 | -1.41 | -1.74 | -1.93 | -3.16 | -4.2 | -3.18 | -3.41 | -4.36 | -6.99 | -8.6 | 19.25 | -18.5 | -22.41 | -36.56 | -21.41 | -28.27 | -24.66 |
EBITDA | -11.03M | -10.67M | -6.71M | -7.41M | -8.06M | -10.29M | -7.09M | -7.09M | -8.92M | -12.9M | -11.27M | -13.7M | -25.53M | -30.57M | -45.49M | -25.2M | -33.56M | -27.49M |
EBIT | -10.07M | -7.86M | -6.78M | -7.47M | -8.12M | -10.35M | -7.16M | -7.25M | -9M | -12.98M | -11.27M | 30.52M | -25.9M | -30.91M | -45.49M | -26.05M | -34.41M | -28.27M |
Depreciation & Amortization | n/a | 68K | 69K | 63K | 61K | 66K | 70K | 157K | 77K | 77K | 80K | 151K | 371K | 338K | 212K | 852K | 845K | 777K |